Global Allergy Diagnostics Market Report 2023-2030: Major Environmental Factors & Growing Number of Food Allergy Cases Fuel Demand

The “Allergy Diagnostics – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.

Global Allergy Diagnostics Market to Reach $8.3 Billion by 2030

The global Allergy Diagnostics market, valued at US$3.8 Billion in 2022, is anticipated to reach US$8.3 Billion by 2030, exhibiting a Compound Annual Growth Rate (CAGR) of 10.3% during the period from 2022 to 2030.

Among the segments analyzed, Assay Kits are expected to lead with an 11% CAGR, reaching US$4.5 Billion by the end of the forecast period. Meanwhile, the Instruments segment is forecasted to achieve a CAGR of 10.1% over the next 8 years.

In terms of regional markets, the U.S. Allergy Diagnostics market is estimated at US$1.3 Billion in 2022. China, as the world’s second-largest economy, is predicted to reach a market size of US$1.1 Billion by 2030, with a remarkable CAGR of 15% between 2022 and 2030.

Other significant geographic markets include Japan and Canada, both expected to grow at CAGRs of 7.7% and 9.8%, respectively, during the 2022-2030 period. Within Europe, Germany is projected to experience substantial growth, with an estimated CAGR of about 9.6%.

What`s New?

  • Special discussions on the global economic climate and market sentiment
  • Coverage on global competitiveness and key competitor percentage market shares
  • Market presence analysis across multiple geographies – Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and trademarked research platform
  • Complimentary updates for one year
  • Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes

Report Highlights

  • Allergy Diagnostics by Geographic Region (Recent Past, Current, and Future Analysis)
  • Allergy Diagnostics by Geographic Region (Historic Review)
  • Allergy Diagnostics by Geographic Region (16-Year Perspective)
  • Assay Kits by Geographic Region
  • Instruments by Geographic Region
  • Services by Geographic Region
  • Inhaled Allergens by Geographic Region
  • Food Allergens by Geographic Region
  • Drug Allergens by Geographic Region
  • Other Allergens by Geographic Region
  • Hospitals by Geographic Region
  • Diagnostic Laboratories by Geographic Region
  • Other End-Uses by Geographic Region
  • Allergy Diagnostics Market Analysis (Annual Sales) for Years 2014 through 2030

MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Allergens: A Prelude
  • Key Allergy Stats
  • Allergy: Symptoms and Causes
  • Allergic Diagnostics: An Introduction
  • Food Allergen Testing
  • Allergy Diagnostics Market Under the Covid Lens
  • Telemedicine Gains Prominence amid the Pandemic
  • Global Allergy Diagnostics Market Set to Witness Rapid Growth
  • With Allergies on the Rise for Whatever Reason Be It Our Neanderthal Genes or Hygiene Hypothesis or Vitamin D Hypothesis, the Need for Effective Diagnostics Has Never Been Greater
  • Global Prevalence of Allergies (In Million)
  • Assay Kits Dominate the Allergy Diagnostics Market
  • Inhaled Allergens Segment to Witness Fastest Growth
  • US Dominates the Allergy Diagnostics Market, While China to Witness the Fastest Growth
  • Rising Demand for In-Vitro Diagnostic Tests for Allergy Diagnosis
  • Global In-Vitro Diagnostics (IVD) Market Revenues (in %) by Segment for the Year 2021
  • Global In-Vitro Diagnostics (IVD) Market Revenues (in %) by Geographic Region for the Year 2021
  • Allergy Diagnostics – Global Key Competitors Percentage Market Share in 2021 (E)
  • Allergy Diagnostics Competitor Market Share Scenario Worldwide (in %): 2021
  • Recent Market Activity
  • Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2021 (E)

MARKET TRENDS & DRIVERS

  • Development of Effective Allergy Diagnostic Products Cuts Down on Healthcare Spending
  • Labs Embrace Automation and Advanced Allergy Tests for Fast Turnaround Times
  • Food Allergies – A Major and Growing Concern
  • Select Digital Technologies to Provide Help in Managing Food Allergy
  • Food Allergies Create Opportunities for Food Allergy Testing
  • ELISA Gains Lead as Preferred Food Testing Method
  • Need to Offer Quality Services at Affordable Costs Prompts Labs to Consider Reagent Rental Agreements
  • In-Vitro IgE Molecular Diagnostics to Transform Allergy Testing Market
  • Macro Array Diagnostics Unveils Allergy Explorer for Allergy Diagnostics
  • Rising Alcohol and Drug Abuse Increases Demand for Allergy Diagnostics
  • Increasing Cases of Allergies Drive Development of Advanced Allergy Diagnostics Solutions
  • Focus on Single and Protein Allergens
  • IgE Antibody Tests
  • Allergy Diagnostic Reagents on Microchip
  • Allergy Diagnosis Moves from Lab-based to Decentralized POC Tests
  • Patch Test to Experience Healthy Growth
  • SmartPractice Secures FDA Approval for T.R.U.E. Test(R) Patch Test for Pediatric Use
  • Providers of Allergy Diagnostic Services Focus on Vertical Integration
  • Allergic Diagnostic Challenges in Patients
  • Enhanced Access to Allergy Diagnosis Medical Insurance & Instrument Allowances in the US Widen Market Prospects
  • Typical Cost Structure for Allergy Testing
  • Technological Advancements – Mobile Health Tools for Allergy Patients
  • Technological Advancements – Nanotechnology for Allergy Diagnostics
  • Application of Nanostructures for In-Vitro Diagnosis of Allergy
  • Application of Nanostructures in Drug-sIgE Detection
  • Application of Nanostructures for Detection of Allergen-sIgE
  • Select Recent Launches in the Allergy Diagnostics Market to Bolster Market Expansion
  • EUROIMMUM Develops EUROLINE DPA-Dx Pollen Southern Europe 1 Test for Pollen Allergies
  • Hycor Biomedical Secures FDA Clearance for NOVEOS Allergy Testing System
  • ASI Introduces IVT Allergy(R) 3 Screen Panel for Allergy Skin Testing
  • CLA-1(TM) Luminometer In-Vitro Allergy Testing Platform for Accurate, Reliable Results
  • Growth Drivers
  • Increasing Prevalence and Incidence of Allergic Disorders to Drive the Demand for Allergy Diagnostics
  • Atopic Dermatitis (Eczema) Prevalence Rates among Global Adult Population
  • Environmental Changes and Pollution Aggravate Incidence of Allergic Reactions, Resulting in Increased Need for Allergy Diagnostics
  • Major Environmental Factors with Link to Allergic Diseases
  • Growing Number of Food Allergy Cases Fuels Demand for Allergy Testing Kits
  • Prevalence Rate of Five Common Food Allergies among US Adults
  • Factors Responsible for Rising Prevalence of Food Allergy
  • Burgeoning Aging Population and Longer Life Expectancy to Drive Allergy Diagnostics Market
  • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Market Restraints
  • Inadequate Knowledge about Food Allergy Inhibits Growth of Allergy Diagnostic Market
  • Expensive Nature of Allergy Diagnostics Approaches Limits Market Growth
  • New Regulations and Statutory Provisions to Affect Diagnostic Allergen Extracts

FOCUS ON SELECT PLAYERS (Total 100 Featured)

  • 3M Company
  • Bausch & Lomb, Inc.
  • ACON Laboratories, Inc.
  • Awareness Technology, Inc.
  • ALK-Abello A/S
  • Allergy Therapeutics Plc
  • Alpha Laboratories Ltd.
  • Angsana Molecular & Diagnostics Laboratory Pte Ltd.
  • Bausch Health Companies Inc.
  • Alkor Bio Group
  • ALLERGOPHARMA GmbH & Co. KG
  • AESKU.Diagnostics GmbH & Co. KG
  • AllerGenis, Inc.
  • Astra Biotech GmbH
  • Assure Tech. (Hangzhou) Co., Ltd

For more information about this report visit here.

Hot this week

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution